早期无创正压通气治疗慢性阻塞性肺疾病合并呼吸衰竭的效果分析

Efficiency analysis of early non-invasive positive pressure ventilation in treating chronic obstructive pulmonary disease complicated with respiratory failure

  • 摘要: 目的 探讨早期无创正压通气治疗慢性阻塞性肺疾病(COPD)合并呼吸衰竭的临床效果。 方法 将90例COPD合并呼吸衰竭患者按治疗方式分为2组,每组45例。对照组行常规对症治疗,研究组在对照组基础上行早期无创正压通气治疗。比较2组患者疗效、治疗转归、治疗前后炎症因子指标变化。 结果 研究组患者有效率高于对照组,无变化率、恶化率低于对照组,差异均有统计学意义(P<0.05)。研究组患者病死率、再入院率均显著低于对照组(P<0.05)。治疗后, 2组白介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)水平均显著下降,且研究组显著低于对照组(P<0.05)。 结论 早期无创正压通气治疗COPD合并呼吸衰竭的疗效显著。

     

    Abstract: Objective To explore the clinical effect of early non-invasive positive pressure ventilation in treating chronic obstructive pulmonary disease(COPD)complicated with respiratory failure. Methods A total of 90 patients with COPD and respiratory failure were divided into two groups according to treatment methods, with 45 cases in each group. The control group received routine symptomatic treatment, and the study group received early non-invasive positive pressure ventilation on the basis of the control group. The therapeutic effect, therapeutic outcome and the changes of inflammatory factors before and after treatment were compared between the two groups. Results The effective rate of the study group was significantly higher than that of the control group, and the rates of no change and deterioration were significantly lower than those of the control group(P<0.05). The mortality and readmission rate in the study group were significantly lower than those in the control group(P<0.05). After treatment, the levels of interleukin-6(IL-6)and tumor necrosis factor-α(TNF-α)significantly reduced in both groups, and levels of these indexes in study group were significantly lower than those in the control group(P<0.05). Conclusion Early non-invasive positive pressure ventilation is effective in the treatment of COPD complicated with respiratory failure.

     

/

返回文章
返回